Titre : Immunisation

Immunisation : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Systemic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Immunisation : Questions médicales les plus fréquentes", "headline": "Immunisation : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Immunisation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-25", "dateModified": "2025-03-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Immunisation" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Prévention primaire", "url": "https://questionsmedicales.fr/mesh/D011322", "about": { "@type": "MedicalCondition", "name": "Prévention primaire", "code": { "@type": "MedicalCode", "code": "D011322", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.780.680" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccination", "alternateName": "Vaccination", "url": "https://questionsmedicales.fr/mesh/D014611", "about": { "@type": "MedicalCondition", "name": "Vaccination", "code": { "@type": "MedicalCode", "code": "D014611", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.780.680.310.890" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vaccination de masse", "alternateName": "Mass Vaccination", "url": "https://questionsmedicales.fr/mesh/D032541", "about": { "@type": "MedicalCondition", "name": "Vaccination de masse", "code": { "@type": "MedicalCode", "code": "D032541", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.780.680.310.890.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Immunisation", "alternateName": "Immunization", "code": { "@type": "MedicalCode", "code": "D007114", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhaochen Ning", "url": "https://questionsmedicales.fr/author/Zhaochen%20Ning", "affiliation": { "@type": "Organization", "name": "Institute of Immunology and Molecular Medicine, Jining Medical University, Jining, China." } }, { "@type": "Person", "name": "Huabao Xiong", "url": "https://questionsmedicales.fr/author/Huabao%20Xiong", "affiliation": { "@type": "Organization", "name": "Institute of Immunology and Molecular Medicine, Jining Medical University, Jining, China." } }, { "@type": "Person", "name": "Heather Miller", "url": "https://questionsmedicales.fr/author/Heather%20Miller", "affiliation": { "@type": "Organization", "name": "Coxiella Pathogenesis Section, Laboratory of Bacteriology Rocky Mountain Laboratories National Institute of Allergy and Infectious Diseases, National Institutes of Health Hamilton Montana USA." } }, { "@type": "Person", "name": "Pamela Lee", "url": "https://questionsmedicales.fr/author/Pamela%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Paediatrics and Adolescent Medicine Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong China." } }, { "@type": "Person", "name": "Chaohong Liu", "url": "https://questionsmedicales.fr/author/Chaohong%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Pathogen Biology School of Basic Medicine Tongji Medical College and State Key Laboratory for Diagnosis and treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology Wuhan Hubei China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.", "datePublished": "2024-08-23", "url": "https://questionsmedicales.fr/article/39273131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms25179182" } }, { "@type": "ScholarlyArticle", "name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36163292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.disamonth.2022.101468" } }, { "@type": "ScholarlyArticle", "name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.chest.2022.09.044" } }, { "@type": "ScholarlyArticle", "name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).", "datePublished": "2022-08-02", "url": "https://questionsmedicales.fr/article/35931315", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.autrev.2022.103167" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36082759", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/BOR.0000000000000904" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Pratiques en santé publique", "item": "https://questionsmedicales.fr/mesh/D015980" }, { "@type": "ListItem", "position": 5, "name": "Prévention primaire", "item": "https://questionsmedicales.fr/mesh/D011322" }, { "@type": "ListItem", "position": 6, "name": "Immunisation", "item": "https://questionsmedicales.fr/mesh/D007114" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Immunisation - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Immunisation", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Immunisation", "description": "Comment diagnostiquer une réaction à un vaccin ?\nQuels tests sont utilisés pour évaluer l'immunité ?\nComment identifier une allergie au vaccin ?\nQuels signes indiquent une infection post-vaccinale ?\nQuand consulter un médecin après une vaccination ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Immunisation", "description": "Quels sont les effets secondaires courants des vaccins ?\nComment reconnaître une réaction allergique au vaccin ?\nLes vaccins peuvent-ils provoquer des symptômes grippaux ?\nQuels symptômes nécessitent une attention médicale après un vaccin ?\nLes enfants peuvent-ils avoir des symptômes après une vaccination ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Immunisation", "description": "Comment prévenir les maladies infectieuses par vaccination ?\nQuels vaccins sont recommandés pour les enfants ?\nComment s'assurer d'une immunisation complète ?\nLes adultes doivent-ils se faire vacciner ?\nComment sensibiliser à l'importance de la vaccination ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Immunisation", "description": "Comment traiter une réaction légère au vaccin ?\nQue faire en cas de réaction allergique au vaccin ?\nLes vaccins nécessitent-ils un suivi médical ?\nComment gérer une fièvre après une vaccination ?\nLes effets secondaires des vaccins nécessitent-ils un traitement ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Immunisation", "description": "Quelles sont les complications possibles des vaccins ?\nComment gérer une complication post-vaccinale ?\nLes complications des vaccins sont-elles fréquentes ?\nQuels sont les signes d'une complication grave ?\nLes vaccins peuvent-ils causer des maladies ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Immunisation", "description": "Quels facteurs augmentent le risque de complications vaccinales ?\nLes personnes âgées ont-elles plus de risques ?\nLes femmes enceintes doivent-elles se faire vacciner ?\nLes antécédents médicaux influencent-ils la vaccination ?\nLes allergies alimentaires affectent-elles la vaccination ?", "url": "https://questionsmedicales.fr/mesh/D007114?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une réaction à un vaccin ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique et des antécédents médicaux sont nécessaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'immunité ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sérologiques mesurant les anticorps spécifiques sont utilisés." } }, { "@type": "Question", "name": "Comment identifier une allergie au vaccin ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané ou un examen allergologique peut être réalisé." } }, { "@type": "Question", "name": "Quels signes indiquent une infection post-vaccinale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, éruption cutanée ou douleur au site d'injection peuvent survenir." } }, { "@type": "Question", "name": "Quand consulter un médecin après une vaccination ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Si des symptômes graves ou inhabituels apparaissent, consultez immédiatement." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants des vaccins ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleur au bras, fièvre légère et fatigue sont fréquents après vaccination." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique au vaccin ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons ou gonflement peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils provoquer des symptômes grippaux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes similaires à la grippe peuvent apparaître temporairement." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une attention médicale après un vaccin ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves comme des difficultés respiratoires doivent être évalués." } }, { "@type": "Question", "name": "Les enfants peuvent-ils avoir des symptômes après une vaccination ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent présenter des symptômes bénins après la vaccination." } }, { "@type": "Question", "name": "Comment prévenir les maladies infectieuses par vaccination ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination régulière selon le calendrier recommandé est essentielle." } }, { "@type": "Question", "name": "Quels vaccins sont recommandés pour les enfants ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre la rougeole, la rubéole et la varicelle sont essentiels." } }, { "@type": "Question", "name": "Comment s'assurer d'une immunisation complète ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Suivez le calendrier vaccinal et consultez un professionnel de santé." } }, { "@type": "Question", "name": "Les adultes doivent-ils se faire vacciner ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccins de rappel et spécifiques sont recommandés pour les adultes." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance de la vaccination ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informez sur les bénéfices des vaccins et partagez des données probantes." } }, { "@type": "Question", "name": "Comment traiter une réaction légère au vaccin ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques comme le paracétamol peuvent soulager la douleur et la fièvre." } }, { "@type": "Question", "name": "Que faire en cas de réaction allergique au vaccin ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Administrez un antihistaminique et consultez un médecin si nécessaire." } }, { "@type": "Question", "name": "Les vaccins nécessitent-ils un suivi médical ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi peut être nécessaire pour les vaccins à doses multiples ou spécifiques." } }, { "@type": "Question", "name": "Comment gérer une fièvre après une vaccination ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Hydratez-vous et prenez des médicaments antipyrétiques si nécessaire." } }, { "@type": "Question", "name": "Les effets secondaires des vaccins nécessitent-ils un traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des effets secondaires sont bénins et ne nécessitent pas de traitement." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des vaccins ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications rares incluent des réactions allergiques sévères ou des convulsions." } }, { "@type": "Question", "name": "Comment gérer une complication post-vaccinale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin pour évaluer et traiter toute complication survenue." } }, { "@type": "Question", "name": "Les complications des vaccins sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Non, les complications graves sont très rares par rapport aux bénéfices des vaccins." } }, { "@type": "Question", "name": "Quels sont les signes d'une complication grave ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Difficultés respiratoires, gonflement du visage ou éruption cutanée sévère." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils causer des maladies ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins ne causent pas les maladies qu'ils préviennent, mais des effets peuvent survenir." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications vaccinales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents d'allergies, immunodépression ou maladies chroniques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les personnes âgées ont-elles plus de risques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un risque accru de complications post-vaccinales." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles se faire vacciner ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations sont recommandées pour protéger la mère et le bébé." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils la vaccination ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents médicaux peuvent nécessiter des ajustements dans le calendrier vaccinal." } }, { "@type": "Question", "name": "Les allergies alimentaires affectent-elles la vaccination ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines allergies alimentaires peuvent nécessiter une évaluation avant la vaccination." } } ] } ] }

Sources (10000 au total)

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.

Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort.... Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?... We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II... In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529... The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with... Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi... Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0... Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....

Scleroderma autoantibodies in guiding monitoring and treatment decisions.

One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia... There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows... ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome.

The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...

Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study.

People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe... The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys... Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by... People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...

[Autoimmune and inflammatory pathologies associated with systemic scleroderma: Clinical, serological and prognostic profiles. Bi-centric retrospective series in the PACA region].

Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc... We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul... The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv... SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...

Juvenile and adult-onset scleroderma: Different clinical phenotypes.

Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare... A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab... A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo... Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....